Prescription trends of topical corticosteroids in dermatological conditions in dr. b. r. ambedkar medical college.

ABSTRACT: BACKGROUND: Currently, topical corticosteroids are most frequently used in dermatological practice. Over the years, research has focused on strategies to optimize potency and, in particular, the anti-inflammatory and immunosuppressive capacity of these drugs, while minimizing the systemic adverse effects. However, ‘ideal’ topical corticosteroids have not yet been synthesised. They should be able to penetrate stratum corneum and reach adequate concentrations. Recently, topical corticosteroids have been synthesized with the aim of having adequate anti-inflammatory effects, while reducing both the local as well as systemic adverse drug reactions. AIM: The study is performed for better understanding of the corticosteroid prescribing habits of dermatologists. MATERIALS AND METHODS: The prescriptions from the outpatient department of Dermatology at Dr. B. R. Ambedkar Medical College were reviewed from 1st June 2012 to 31st August 2012, to know the current prescribing trends. RESULTS: The patient's name, age and sex were on 100%, 98.7% and 55.3% of prescriptions. The majority (53.5%) of the prescriptions were for males. All topical corticosteroids were prescribed by brand name; strength of medication and dose units were included in 89.3% and 67.2% of prescriptions. No prescription contained the patient's address and weight, diagnosis and instruction to the pharmacist. Special instructions to the patient were mentioned in 29.5% prescriptions. The prescriber's handwriting was illegible in 77.1% of prescriptions. The prescriber's name, address and signature were on 54.1%, 100% and 100% of prescriptions respectively. In 46.32% instances, moderate-high potency and 10.53% instances, mild potency topical corticosteroids were prescribed. CONCLUSIONS: The prescribers should adhere to the prescription format and encourage prescribing by generic name, from essential drug list which should be updated regularly.